Meet the Researcher: Yubing Xia
My research focuses on HER2-positive breast cancer, a type of breast cancer that is treated with a targeted drug called trastuzumab before surgery. I am investigating how a patient’s immune system influences how well this treatment works. We believe that a patient’s overall “immune readiness” before treatment may help predict whether they will respond well. […]
Innovation and Progress in 2026
From more targeted treatments to new ways of monitoring cancer and improving care, research is changing what is possible in breast cancer. Breast cancer research is moving quickly. Across Canada and around the world, researchers are learning more about how breast cancer develops, why it behaves differently from person to person, and how treatment can […]
INDUSTRY NEWS: The Next Chapter of Progress in HER2-Positive Early Breast Cancer
A significant step toward improving access to treatment for Canadians with HER2-positive early breast cancer was reached this month, following the completion of negotiations between Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) for Perjeta (pertuzumab) in the neoadjuvant setting. The agreement brings Canadian patients one step closer to publicly funded access to Perjeta in […]
REAL Alliance National Clinical Recommendations Webinar
Breast cancer treatment is evolving faster than ever. New clinical evidence, emerging therapies, and advances in personalized care continue to reshape how patients are diagnosed, treated, and supported across the country. As innovation accelerates, ensuring consistent, evidence-based care for every patient—regardless of where they live—remains essential. On September 3, 2026, healthcare professionals from across Canada […]
Canadian Night at ESMO 2026
Breast Cancer Canada is pleased to once again bring the Canadian breast cancer community together during the European Society for Medical Oncology (ESMO) Congress. On Saturday, October 24, 2026, Breast Cancer Canada will host Canadian Night at ESMO, an evening reception dedicated to connecting Canadian researchers, clinicians, patient advocates, industry partners and healthcare leaders attending this year’s […]
Quality of Life Must Be Part of Breast Cancer Care
For many people affected by breast cancer, treatment does not end when active therapy is complete. Long after diagnosis, individuals may continue to experience side effects that affect their daily lives, including hot flashes, night sweats, sleep disruption, fatigue, and other symptoms associated with medically induced menopause. For those receiving endocrine therapies such as tamoxifen […]
Meet the Researcher: Isabel Kannampuzha
Isabel Kannampuzha is an MSc student in the Department of Anatomy & Cell Biology atWestern University. She is conducting BCC-funded breast cancer research under thementorship of Dr. Armen Parsyan and Dr. Alison Allan.
Meet the Researcher: Yan Yi Li
Yan Yi Li is a PhD student in the Department of Biochemistry at Western University. She is conducting BCC-funded breast cancer research under the mentorship of Dr. Pingzhao Hu. My research focuses on finding new treatments for triple-negative breast cancer (TNBC), one of the most aggressive forms of breast cancer and one that still has […]
National Committee on Preventive Health
Breast Cancer Canada welcomes the Government of Canada’s announcement of the National Advisory Committee on Preventive Health Services and its commitment to evidence-based, transparent, and equitable preventive health care. Preventive health guidelines have a profound impact on the health outcomes of Canadians. For breast cancer patients, screening recommendations can influence when cancers are detected, treatment […]
Male Breast Cancer
June is Men’s Health Month, a time usually dedicated to conversations around heart health, prostate checks, and mental well-being. But there is another critical health topic that often gets left out of the locker room talk: breast cancer. While it is significantly less common in men than in women, it is no less serious. The […]
